Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01917825 · ClinicalTrials.gov registry record · Phase 2

A Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy

A Phase 2 study of Sciatica and Lumbosacral Radiculopathy, sponsored by Medtronic Spinal and Biologics.

Completed
Registry status
Phase 2
Development phase
54
Enrollment target
6
Study locations

NCT01917825: Completed Phase 2 study of Sciatica and Lumbosacral Radiculopathy, sponsored by Medtronic Spinal and Biologics.

NCT01917825 is a Phase 2 study of Sciatica and Lumbosacral Radiculopathy that has completed, run by Medtronic Spinal and Biologics. The registered enrollment target is 54 participants, below the 78-participant average among 6 other Sciatica trials with a reported enrollment target (31% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01917825, a Phase 2 study of Sciatica and Lumbosacral Radiculopathy, has completed, sponsored by Medtronic Spinal and Biologics.

COMPLETED
Registry status
Phase 2
Development phase
54 participants
Enrollment target
6
Study locations

Study Summary

The primary objectives of this clinical trial are to investigate the pharmacokinetics and safety of MDT-15 pellets in escalating sequential doses administered to different cohorts. Preliminary efficacy data will also be collected for assessment.

Primary Outcome

The Pharmacokinetics profile (Cmax, Tmax, AUC0-t, and AUC0-∞) following administration of up to six MDT-15 pellets in escalating sequential doses to different cohorts will be evaluated.

Interventions

  • DRUG MDT-15

Study Locations (6)

Indiana

  • Indiana Spine Group - Carmel
  • Franciscan St Francis Pain and Spine Center - Indianapolis

Florida

  • Holy Cross Orthopedic Institute - Fort Lauderdale

Illinois

  • Millennium Pain Center - Bloomington

Kentucky

  • Otrimed Clinical Research - Edgewood

Missouri

  • Pain and Rehabilitation Specialists - St Louis

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2013-07
Est. Completion 2016-10
Phase Phase 2
Medtronic Spinal and Biologics

26 total trials

What the finished NCT01917825 record still lists

NCT01917825 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 78-participant average among 6 other Sciatica trials with a reported enrollment target (31% lower).

The record links to 2 conditions, with Sciatica appearing as the primary indexed condition, and to 1 intervention - of which MDT-15 is the first listed.

NCT01917825 lists 6 locations in 5 states (Indiana, Florida, Illinois).

Frequently Asked Questions

What is clinical trial NCT01917825 about?

NCT01917825 is a clinical study titled "A Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy". The primary objectives of this clinical trial are to investigate the pharmacokinetics and safety of MDT-15 pellets in escalating sequential doses administered to different cohorts. Preliminary efficacy data will also be collected for assessment.

What is the current status of trial NCT01917825?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 54 participants. The study started on 2013-07. Estimated completion is 2016-10.

What conditions does trial NCT01917825 study?

This clinical trial studies the following conditions: Sciatica, Lumbosacral Radiculopathy.

What interventions are being tested in trial NCT01917825?

The interventions under investigation include: MDT-15 (DRUG).

Who is sponsoring clinical trial NCT01917825?

This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01917825 being conducted?

This trial has 6 study locations across Florida, Illinois, Indiana, Kentucky, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sciatica

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01269853 · 54 participants · Phase 1

    Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

  • NCT02390752 · 54 participants · Phase 1

    Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

  • NCT02991248 · 54 participants · NA

    Improve Dynamic Lateral Balance of Humans With SCI

  • NCT02993900 · 54 participants · NA

    Image-Guided Gynecologic Brachytherapy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01917825, the US trial registry maintained by the National Library of Medicine. NCT01917825 (small enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.